![](/img/cover-not-exists.png)
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
Huang, Wei-Chieh, Huang, Chun-Kai, Huang, Sung-Hsi, Lin, Shu-Wen, Ou, Shyh-Tyan, Chen, Yi-Ting, Chen, Ya-Wen, Chang, Shu-Yuan, Liu, Wen-Chun, Sun, Hsin-Yun, Hung, Chien-ChingJournal:
Journal of Microbiology, Immunology and Infection
DOI:
10.1016/j.jmii.2020.06.010
Date:
July, 2020
File:
PDF, 727 KB
2020